close

RQM+ announces investment by Linden Capital Partners

Maria Fagan cropped

RQM+ has announced an investment by Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm.

Headquartered in Pennsylvania, RQM+ is the largest international provider of regulatory, quality and compliance consulting services dedicated to medical device and in-vitro diagnostics manufacturers.

The organisation said the investment will help accelerate growth and expand the breadth of its services.

Story continues below
Advertisement

Maria Fagan (pictured), CEO of RQM+, stated: “We are extremely proud of the business we have built at RQM+ and excited to partner with Linden to accelerate our growth and expand the breadth of services we can provide to our customers. We chose the Linden team as our partner for the next phase of our growth due to their exclusive focus on healthcare investing and shared vision for RQM+.”

Richard Thomas, incoming board member of RQM+ and industry veteran, said: “We commend Maria Fagan, Lisa Casavant and the entire management team at RQM+ on building an extraordinary business providing superior quality and services that are essential to helping their clients navigate a dynamic and increasing complex regulatory landscape.

“As manufacturers accelerate product and technology innovation to meet future healthcare needs, RQM+ is uniquely positioned to support the industry with an expanding suite of end-to-end capabilities and approaches to strategic partnership.”

Michael Farah, a Partner at Linden and incoming board member of RQM+, added: “Our investment in RQM+ is a direct result of our dedicated and longstanding outsourced medical device services sector effort, and we are excited to partner with an organization with such a strong market reputation in a highly fragmented industry.

“We look forward to supporting the entire RQM+ team as they seek to grow both organically and through acquisitions.” 

Tags : investmentLinden Capital PartnersRQM+
Sarah Clarke

The author Sarah Clarke

Leave a Response